Bilal Arif
Chief Operations Officer · KalVista Pharmaceuticals, Inc.
Individual
- 2025
- Jun 11, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bilal Arif files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Venrock Healthcare Capital Partners III, L.P. - $3.69M in KALV purchases and sales in the last 12 months
- Christopher Yea - $1.23M in KALV purchases and sales in the last 12 months
- Benjamin L. Palleiko - $1.19M in KALV purchases and sales in the last 12 months
- Paul K. Audhya - $430K in KALV purchases and sales in the last 12 months
- Ian Michael Estepan - $294K in SRPT purchases and sales in the last 12 months
- Nicole Sweeny - $241K in KALV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bilal Arif?
Bilal Arif is a corporate insider, tracked as Chief Operations Officer of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Bilal Arif last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 4 filings going back to 2025.
